About Veralight
Veralight is a company based in Albuquerque (United States) founded in 2004. It operates as a B2B. Veralight has raised $25.23 million across 4 funding rounds from investors including Dow, Psilos Group and Garywoitzik. Veralight operates in a competitive market with competitors including Viome Life Sciences, Proteomics International, Tethys BioScience, Mellitus and SmartZyme, among others.
- Headquarter Albuquerque, United States
- SectorsHealthcare
- Website thescoutds.com
- Social Facebook
- Total Equity Funding$25.23M (USD)
in 4 rounds
- Latest Funding Round$200K (USD), Series C
Dec 2012
- InvestorsDow
& 4 more
Funding Insights of Veralight
Veralight has successfully raised a total of $25.23M across 4 strategic funding rounds. The most recent funding activity was a Series C round of $200 thousand completed in December 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $25.23M
- Total Rounds 4
- Last Round Series C — $200,000
- First Round $17.5M
(Aug 2006)
- Investors Count 5
All 4 funding rounds of Veralight with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2012 | $200,000 | Series C | – | – | – |
| Jun 2012 | $2.53M | Series C | – | – | – |
| Jul 2011 | $5M | Series C | – | – | – |
| Aug 2006 | $17.5M | Series B | – | – |
5 investors in total: 5 institutional.
Investors in Veralight
Veralight has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Dow, Psilos Group and Garywoitzik.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Growth-stage investments focused on US tech and life sciences. | – | psilos.com | New York, United States | |
Early-stage investments in US tech and life sciences are targeted. | – | spv.com | Salt Lake City, United States | |
- | – | garywoitzik.com | - | |
Operates as a funds investment management firm providing advisory services. | 1975 | wasatchfunds.com | Salt Lake City, United States | |
Dow Inc. is engaged in materials science and chemical manufacturing. | 1897 | dow.com | Saginaw, United States |
Investor details for Veralight
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Veralight
3 dated milestones of Veralight across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Veralight is founded.
- Funding First funding round of $17.5M.
- Funding Latest funding round, Series C, of $200K.
Competitors of Veralight
Veralight operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Viome Life Sciences, Proteomics International, Tethys BioScience, Mellitus and SmartZyme, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| viomelifesciences.com | 2016 | Bothell, United States | $92.44M | 136 | Provider of tests to prevent, treat, and cure chronic diseases, and cancer | |
| proteomics.com.au | 2001 | Perth, Australia | – | – | Medical technology company at the forefront of predictive diagnostics and bio-analytical services | |
| tethysbio.com | 2002 | Emeryville, United States | $53.3M | 81 | Develops biological markers for medical diagnostic applications. | |
| mellitusllc.com | 2011 | Boston, United States | $16.1M | – | In vitro diagnostic test for Gestational Diabetes Mellitus (GDM) | |
| smzyme.com | 2013 | Herzliya Pituach, Israel | $4M | – | Proprietary protein engineering technology is developed for diabetes products. | |
| sensotrend.com | 2013 | Tampere, Finland | – | – | Automated diabetes diary is offered for blood sugar monitoring. | |
| accessiblediagnostics.com | 2014 | Greenville, United States | $548,500 | – | Delivers comprehensive glucose monitoring device solutions. | |
| patiadiabetes.com | 2013 | Mexico | – | – | Genetic tests for type 2 diabetes risk assessment are developed. |
Detailed competitors of Veralight
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Veralight
Complete news archive for Veralight
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Veralight
10 companies that operate in the same segment as Veralight (Diabetes), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of devices for continuous glucose monitoring and manual insulin delivery | 2008 | San Diego, California, United States | USD 100.73 M | USD 1.02 B | 2,650 | |
Wearable glucose monitoring patches are provided for real-time data tracking. | 1999 | San Diego, California, United States | USD 52.5 M | USD 4.66 B | 10,300 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Small molecule drugs for various therapeutic areas are developed. | 1995 | United States | USD 165 M | USD 49.8 M | 103 | |
Implantable continuous glucose monitoring systems are provided for diabetes management. | 1996 | Germantown, United States | USD 175.46 M | USD 22.47 M | 117 | |
Developer of a closed-loop automated insulin delivery system | 2014 | Milpitas, California, United States | USD 214.51 M | – | 133 | |
Provider of workforce healthcare solutions | 2015 | New York, New York, United States | USD 107.87 M | – | 166 | |
Diabetes care and reversal programs are provided to patients. | 2021 | Bengaluru, Karnataka, India | USD 26.7 M | USD 5.07 M | 677 | |
Provider of smart devices for diabetes management for patients and doctors | 2014 | San Francisco, California, United States | USD 245.2 M | – | – | |
Genetically engineered cell therapies are developed for multiple disorders. | 2018 | Seattle, Washington, United States | USD 821 M | – | 194 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Veralight
Veralight was founded in 2004 and raised its 1st funding round 2 years after it was founded.
Veralight is headquartered in Albuquerque, United States. It is registered at Albuquerque, New Mexico, United States.
Veralight is a funded company, having raised a total of $25.23M across 4 funding rounds to date. The company's 1st funding round was a Series B of $17.5M, raised on Aug 2006.
Veralight, based in Albuquerque, focuses on providing healthcare solutions, medical diagnostics, biomarker screening, and diabetes detection. Offers biomarker screening solutions for early diabetes detection. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.
Veralight's top competitors include Viome Life Sciences, Proteomics International and Mellitus.
Veralight has 5 investors. Key investors include Dow, Psilos Group, Garywoitzik, Wasatch Advisors, and Signal Peak.